Caricamento...
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options. We report our 12-y experience of antithymocyte globulin (ATG) as second-line CLAD therapy. METHODS. Clinical and lung function data were collect...
Salvato in:
| Pubblicato in: | Transplant Direct |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969305/ https://ncbi.nlm.nih.gov/pubmed/33748410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001134 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|